Rainbow Equine Hospital Limited Accounts


Rainbow Equine Hospital Limited FILLETED ACCOUNTS COVER
Rainbow Equine Hospital Limited
Company No. 08825966
Information for Filing with The Registrar
31 December 2016
Rainbow Equine Hospital Limited DIRECTORS REPORT REGISTRAR
The Directors present their report and the accounts for the year ended 31 December 2016.
Principal activities
The principal activity of the company during the year under review was Veterinary Surgeons.
Directors
The Directors who served at any time during the year were as follows:
J.D.C. Anderson
M.J. Brennan
I.V. Pritchard
J.B.C. Reed
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
J.D.C. Anderson
Director
28 September 2017
Rainbow Equine Hospital Limited BALANCE SHEET REGISTRAR
at
31 December 2016
Company No.
08825966
Notes
2016
2015
£
£
Fixed assets
Tangible assets
2
799,449832,252
Investments
3
5050
799,499832,302
Current assets
Stocks
4
43,50044,000
Debtors
5
758,989723,300
Cash at bank and in hand
1,080,351399,950
1,882,8401,167,250
Creditors: Amount falling due within one year
6
(1,495,414)
(1,312,902)
Net current assets/(liabilities)
387,426
(145,652)
Total assets less current liabilities
1,186,925686,650
Provisions for liabilities
Deferred taxation
7
(79,405)
(105,805)
Net assets
1,107,520580,845
Capital and reserves
Called up share capital
6060
Profit and loss account
8
1,107,460580,785
Total equity
1,107,520580,845
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
For the year ended 31 December 2016 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 28 September 2017
And signed on its behalf by:
I.V. Pritchard
Director
28 September 2017
Rainbow Equine Hospital Limited NOTES TO THE ACCOUNTS REGISTRAR
for the year ended 31 December 2016
1
Accounting policies
Basis of preparation
The accounts have been prepared in accordance with FRS 102 - The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard) and the Companies Act 2006 . There were no material departures from that standard.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets and in accordance with the accounting policies set out below.
Turnover
Turnover is measured at the fair value of the consideration received or receivable. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.

Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible timing differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.

Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period.

Current or deferred tax for the year is recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Leasehold land and buildings
10% Straight line
Plant and machinery
20% Reducing balance
Motor vehicles
20% Reducing balance
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Net realisable value is based on the estimated selling price less any estimated completion or selling costs.
Trade and other debtors
Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method, less impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
Leased assets
Where the company enters into a lease which entails taking substantially all the risks and rewards of ownership of an asset, the lease is treated as a finance lease.
Leases which do not transfer substantially all the risks and rewards of ownership to the Company are classified as operating leases.
Assets held under finance leases are initially recognised as assets of the Company at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the balance sheet date as a finance lease obligation. Lease payments are apportioned between finance expenses and reduction of the lease obligation so as to achieve a constant rate of interest on the remaining balance of the liability. Finance expenses are recognised immediately in profit or loss, unless they are directly attributable to qualifying assets, in which case they are capitalised in accordance with the Company's policy on borrowing costs (see the accounting policy above).
Assets held under finance leases are depreciated in the same way as owned assets.

Operating lease payments are recognised as an expense on a straight-line basis over the lease term.
Pensions
The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the company pays fixed contributions into a separate entity. Once the contributions have been paid the company has no further payments obligations. The contributions are recognised as expenses when they fall due. Amounts not paid are shown in accruals in the balance sheet. The assets of the plan are held separately from the company in independently administered funds.
Provisions
Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to the profit and loss account in the year that the Company becomes aware of the obligation, and are measured at the best estimate at balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the balance sheet.
2
Tangible fixed assets
Land and buildings
Plant and machinery
Motor vehicles
Total
£
£
£
£
Cost or revaluation
At 1 January 2016
366,800676,36017,6371,060,797
Additions
48,09793,90513,600155,602
At 31 December 2016
414,897770,26531,2371,216,399
Depreciation
At 1 January 2016
39,947184,4064,192228,545
Charge for the year
37,495144,6636,247188,405
At 31 December 2016
77,442329,06910,439416,950
Net book values
At 31 December 2016
337,455441,19620,798799,449
At 31 December 2015
326,853491,95413,445832,252
3
Investments
Investment in Joint venture
Total
£
£
Cost or valuation
At 1 January 2016
5050
At 31 December 2016
5050
Net book values
At 31 December 2016
5050
At 31 December 2015
5050
4
Stocks
2016
2015
£
£
Raw materials and consumables
43,50044,000
43,50044,000
5
Debtors
2016
2015
£
£
Trade debtors
714,452679,642
Loan owed by Participating interest
10,00010,000
Prepayments and accrued income
34,53733,658
758,989723,300
6
Creditors:
amounts falling due within one year
2016
2015
£
£
Trade creditors
105,898127,769
Corporation tax
214,280150,858
Other taxes and social security
155,572118,127
Loans from directors
994,584897,420
Accruals and deferred income
25,08018,728
1,495,4141,312,902
7
Provisions for liabilities
Deferred taxation
Accelerated capital allowances, losses and other timing differences
Arising from revaluation
Total
£
£
£
At 1 January 2016
105,805
-105,805
Charge to the profit and loss account for the period
(26,400)
(26,400)
At 31 December 2016
79,405
-79,405
2016
2015
£
£
Accelerated capital allowances
79,405105,805
79,405105,805
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
9
Dividends
2016
2015
£
£
Dividends for the period:
Dividends paid in the period
288,000
252,000
288,000252,000
Dividends by type:
Equity dividends
288,000252,000
288,000
252,000
10
Related party disclosures
2016
2015
Transactions with related parties
£
£
Name of related party
Rainbow Equine Reproductive Services Limited
Description of relationship between the parties
This is a joint venture and Rainbow Equine Hospital Ltd owns 50% of the issued share capital
Description of transaction and general amounts involved
Management and administration services and loan advanced
Amount due from/(to) the related party
21,82018,850
Controlling parties
Immediate controlling parties
I V Pritchard, J D C Anderson M J Brennan, J B C Reed
11
Additional information
Its registered number is:
08825966
Its registered office is:
1 Wheelgate
Malton
North Yorkshire
YO17 7HT
Rainbow Equine Hospital Limited0882596631 December 201601 January 2016false28 September 2017BTCSoftware AP Solution 2017 4.5.06true088259662016-01-012016-12-31088259662016-12-31088259662015-12-3108825966core:WithinOneYear2016-12-3108825966core:WithinOneYear2015-12-3108825966core:ShareCapital2016-12-3108825966core:ShareCapital2015-12-3108825966core:RetainedEarningsAccumulatedLosses2016-12-3108825966core:RetainedEarningsAccumulatedLosses2015-12-3108825966core:LeasedAssetsHeldAsLesseecore:LandBuildings2016-01-012016-12-3108825966core:PlantMachinery2016-01-012016-12-3108825966core:MotorVehicles2016-01-012016-12-3108825966core:LandBuildings2016-01-0108825966core:PlantMachinery2016-01-0108825966core:MotorVehicles2016-01-01088259662016-01-0108825966core:LandBuildings2016-01-012016-12-3108825966core:LandBuildings2016-12-3108825966core:PlantMachinery2016-12-3108825966core:MotorVehicles2016-12-3108825966core:LandBuildings2015-12-3108825966core:PlantMachinery2015-12-3108825966core:MotorVehicles2015-12-3108825966core:CostValuation2016-01-0108825966core:CostValuation2016-12-3108825966core:CostValuationcore:UnlistedNon-exchangeTraded2016-12-3108825966core:RevaluationPropertyPlantEquipmentDeferredTax2016-01-0108825966core:RevaluationPropertyPlantEquipmentDeferredTax2016-12-3108825966core:AcceleratedTaxDepreciationDeferredTax2016-12-3108825966core:AcceleratedTaxDepreciationDeferredTax2015-12-3108825966core:RetainedEarningsAccumulatedLosses2016-01-012016-12-31088259662015-01-012015-12-3108825966core:EntityWithJointControlOrSignificantInfluence12016-01-012016-12-3108825966core:EntityWithJointControlOrSignificantInfluence12016-12-3108825966core:EntityWithJointControlOrSignificantInfluence12015-12-3108825966bus:RegisteredOffice2016-01-012016-12-3108825966bus:SmallEntities2016-01-012016-12-3108825966bus:FullAccounts2016-01-012016-12-3108825966bus:AuditExempt-NoAccountantsReport2016-01-012016-12-3108825966bus:Director32016-01-012016-12-3108825966bus:PrivateLimitedCompanyLtd2016-01-012016-12-31iso4217:GBP